Format

Send to

Choose Destination
J Vasc Interv Radiol. 2019 Mar;30(3):342-346. doi: 10.1016/j.jvir.2018.11.026.

Balloon-Occluded Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single-Center US Preliminary Experience.

Author information

1
Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1184 Fifth Ave., MC Level, New York, NY 10029. Electronic address: goldmadt@gmail.com.
2
Department of Radiology, Santa Barbara Cottage Hospital, Santa Barbara, California.
3
Division of Interventional Radiology, Icahn School of Medicine at Mount Sinai, 1184 Fifth Ave., MC Level, New York, NY 10029.

Abstract

This report describes a single-center experience with balloon-occluded transarterial chemoembolization for liver-directed therapy. A total of 26 patients (11 male, 4 female; mean age, 65 y ± 7) with 28 tumors (mean diameter, 2.7 cm; range, 1.1-5.9 cm) were treated. Technical success rate was 100% (28 of 28 cases), with 1 minor complication of left portal vein thrombosis and small liver infarct. Of the 15 tumors analyzed for response, 60% (9 of 15) exhibited complete response, 33.3% (5 of 15) exhibited partial response, and 6.6% (1 of 15) had stable disease on follow-up. Eight patients exhibited overall progression with a new hepatic lesion and a median time to progression of 7.9 months (range, 5-11 mo).

PMID:
30819475
DOI:
10.1016/j.jvir.2018.11.026

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center